Bronchiectasis

October 12, 2016October 12, 2016

Insmed Reaches Agreement with AstraZeneca for Potential Bronchiectasis Therapy

Bronchiectasis, News

Insmed Incorporated, a biopharmaceutical company focused on rare diseases, disclosed a licensing agreement with AstraZeneca for global exclusive rights to AZD7986, a new oral, reversible inhibitor of dipeptidyl peptidase I (DPP1, aka ... Read more

June 21, 2016June 21, 2016

AffloVest Receives CE Mark Approval for Use in Europe and Elsewhere

Bronchiectasis, Cystic Fibrosis, News

International Biophysics Corporation, an international-American medical device manufacturer, recently announced that they received CE Mark, and approval from Health Canada and the Australian Therapeutic Goods Administration (TGA), for their product ... Read more

May 16, 2016May 16, 2016

Aradigm’s Candidates for NCFBE Featured at ATS 2016

Bronchiectasis, Cystic Fibrosis, News

The American Thoracic Society (ATS) is hosting the ATS 2016 International Conference through May 18 in San Francisco, Calif. Aradigm, an emerging pharmaceutical focused on drugs for the prevention and ... Read more

March 22, 2016May 13, 2016

FDA Designation to Speed Testing of Inhaled Antibiotic, Levofloxacin, to Treat Lung Infections

Bronchiectasis, Cystic Fibrosis, News

Raptor Pharmaceutical Corp. announced that its proprietary inhaled levofloxacin, MP-376, has been given Qualified Infectious Disease Product (QIDP) designation by the U.S. Food and Drug Administration (FDA) to treat three specific indications: ... Read more

March 14, 2016March 16, 2016

RespirTech Introduces Cystic Fibrosis Treatment Remote Monitoring System

Bronchiectasis, COPD, Cystic Fibrosis, News

RespirTech, an important provider of airway clearance therapy vests, is developing an innovative way for clinicians to remotely monitor the treatment of cystic fibrosis (CF) patients, funded by a Small Business Innovation Research (SBIR) ... Read more

March 2, 2016March 2, 2016

AffloVest, for Lung and Respiratory Conditions, to Be Made in the USA

Bronchiectasis, Cystic Fibrosis, News

International Biophysics Corp. recently announced that the company will now manufacture its AffloVest in the United States. AffloVest is the first portable High Frequency Chest Wall Oscillation (HFCWO) medical device which can provide critical ... Read more

February 2, 2016February 3, 2016

FDA Approves IND Application for Multidrug-Resistant Bacterial Infections

Bronchiectasis, COPD, Cystic Fibrosis, Emphysema, News, Pneumonia

Matinas BioPharma Holdings recently announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application, and the company can now begin a Phase 1 clinical trial to ... Read more

January 28, 2016January 28, 2016

UC San Diego Researchers Develop Novel Detection Method for Antibiotics Resistance

Bronchiectasis, COPD, Cystic Fibrosis, News, Pneumonia

A recent article by UC San Diego researchers, published in the journal EBioMedicine, reported the development of a novel, rapid and efficient technique able to determine whether bacteria are resistant to ... Read more

January 15, 2016

Matinas BioPharma Fills IND Application for Antibacterial Drug Development

Bronchiectasis, COPD, Cystic Fibrosis, News

Matinas BioPharma of Bedminster, N.J., filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for the development of its antibacterial drug MAT2501 for the ... Read more

December 9, 2015December 9, 2015

Airway Clearance Therapy Helps in Range of Lung Diseases

Bronchiectasis, News

Airway clearance therapy (ACT) is an important treatment approach for patients with impaired ciliary function or other difficulties in clearing the lungs of mucus and harmful particles. Evidence indicates that ACT minimizes ... Read more